Evidence map›Paper›PMID 32918342›Full record

ArticleJournal of clinical nursing2022

Involuntary treatment in dementia care at home: Results from the Netherlands and Belgium.

Angela M H J Mengelers, Vincent R A Moermans, Michel H C Bleijlevens, Hilde Verbeek, Elizabeth Capezuti, Frans Tan, Koen Milisen, Jan P H Hamers

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical nursing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 5 countries.

Angela M H J MengelersFaculty of Health, Medicine and Lifesciences, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.ORCID https://orcid.org/0000-0002-0010-9458
Vincent R A MoermansFaculty of Health, Medicine and Lifesciences, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Michel H C BleijlevensFaculty of Health, Medicine and Lifesciences, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Hilde VerbeekFaculty of Health, Medicine and Lifesciences, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Elizabeth CapezutiHunter College, The Graduate Center of City University of New York, New York, NY, USA.
Frans TanFaculty of Health, Medicine and Lifesciences, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Koen MilisenDepartment of Public Health & primary Care, Academic Centre for Nursing and Midwifery, KU Leuven, Leuven, Belgium.
Jan P H HamersFaculty of Health, Medicine and Lifesciences, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Maastricht University · NLDepartment of Public Health · MMThe Graduate Center, CUNY · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AIMS AND

objectivesTo gain insight into the request, use and associated factors of involuntary treatment in people with dementia (PwD) receiving professional home care in the Netherlands and Belgium.

backgroundMost of the PwD remain living at home as long as possible. Due to complex care needs, this can result in an increased risk for care provided against the wishes of the client and/or to which the client resists, referred to as involuntary treatment.

designSecondary data analyses of two cross-sectional surveys.

methodsDementia case managers and district nurses filled in a questionnaire for each PwD in their caseload. This study included data of 627 PwD receiving professional home care in the Netherlands and 217 in Belgium. The same methodology (questionnaire and variables) was used in both samples. Descriptive statistics and multi-level logistic regression analyses were used to analyse the data. The study adhered to the STROBE checklist.

resultsMore than half of the PwD (50.7%) living at home received involuntary treatment (Belgium 68.2% and the Netherlands 44.7%). Nonconsensual care (82.7%) was the most common, followed by psychotropic medication (40.7%) and physical restraints (18.5%). Involuntary treatment use was associated with living alone, greater ADL dependency, lower cognitive ability, higher family caregiver burden and receiving home care in Belgium versus the Netherlands. Involuntary treatment was most often requested by family caregivers.

conclusionsInvoluntary treatment is often used in PwD, which is in line with previous findings indicating dementia as a risk factor for involuntary treatment use. More research is needed to gain insight into variations in prevalence across other countries, which factors influence these differences and what countries can learn from each other regarding prevention of involuntary treatment. RELEVANCE TO CLINICAL PRACTICE: To provide person-centred care, it is important to study ways to prevent involuntary treatment in PwD and to stimulate dialogue between professional and family caregivers for alternative interventions.

Indexed as

DementiaInvoluntary TreatmentBelgiumCaregiversCross-Sectional StudiesHumansNetherlandscommunity carecommunity nursingdementiadementia caredistrict nursing

Identifiers

PMID32918342
PMCPMC9292312
OpenAlexW3048453180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.